InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

Wall Street expects a year-over-year increase in earnings on higher revenues when InMode (INMD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...

Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic ...

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...

Good day, and welcome to the InMode's third-quarter 2024 earnings results conference call. [Operator instructions] Please note this event is being recorded. I would now like to hand the call to Miri ...

Inmode ( (INMD)) has released its Q3 earnings. Here is a breakdown of the information Inmode presented to its investors. InMode Ltd. is a global provider of innovative medical technologies, ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a ...

InMode INMD is preparing to release its quarterly earnings on Monday, 2025-04-28. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect InMode to ...

InMode Ltd. beats earnings expectations. Reported EPS is $0.47, expectations were $0.43. Operator: Good day, and welcome to InMode’s Second Quarter 2025 Earnings Results Conference Call. [Operator ...